| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO | Director
2 companies
Raab Michael is a President &CEO at ARDELYX, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 14 sells.
Estimated insider holdings value: $11.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2024 | ARDX Ardelyx, Inc. | President &CEO | Sell | 22,917 | $8.75 | $200,438.96 | -1.7% | -7.3% | -25.6% | |
| Nov 20, 2023 | ARDX Ardelyx, Inc. | President &CEO | Sell | 11,368 | $4.36 | $49,589.49 | -1.3% | +95.2% | +9.4% | |
| Aug 21, 2023 | ARDX Ardelyx, Inc. | President &CEO | Sell | 11,419 | $3.55 | $40,558.00 | -1.3% | +22.3% | +70.9% | |
| May 23, 2023 | ARDX Ardelyx, Inc. | President &CEO | Sell | 11,357 | $3.65 | $41,489.39 | -1.3% | +0.3% | +119.0% | |
| Mar 17, 2023 | FOLD Amicus Therapeutics, Inc. | Director | Sale+OE | 4,408 | $11.33 | $49,942.64 | -6.8% | +15.3% | +2.1% | |
| Feb 21, 2023 | ARDX Ardelyx, Inc. | President &CEO | Sell | 13,449 | $3.00 | $40,360.45 | -1.5% | +21.1% | +189.1% | |
| Nov 22, 2022 | ARDX Ardelyx, Inc. | President &CEO | Sell | 6,219 | $1.95 | $12,120.29 | -0.3% | +58.9% | +133.0% | |
| Aug 31, 2022 | ARDX Ardelyx, Inc. | President &CEO | Buy | 3,000 | $0.62 | $1,856.40 | +0.5% | +84.6% | +349.4% | |
| Aug 22, 2022 | ARDX Ardelyx, Inc. | President &CEO | Sell | 6,146 | $0.98 | $6,045.36 | -0.3% | +107.0% | +251.0% | |
| Jun 6, 2022 | ARDX Ardelyx, Inc. | President &CEO | Sell | 103,624 | $0.65 | $67,416.27 | -7.2% | +76.6% | +482.8% |